R/R AML

Clinical trials for R/R AML explained in plain language.

Never miss a new study

Get alerted when new R/R AML trials appear

Sign up with your email to follow new studies for R/R AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

First patients to receive experimental drug for aggressive leukemia

Disease control Recruiting now

This is the first-ever study in people for a new drug called GEN3018. It aims to find a safe and effective dose for adults with acute myeloid leukemia or myelodysplastic syndrome that has returned or is resistant to standard treatments. The main goals are to check the drug's safe…

Matched conditions: R/R AML

Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

R/R AML

Get alerted when new R/R AML trials appear

First patients to receive experimental drug for aggressive leukemia